Loading clinical trials...
Loading clinical trials...
The ability to explain bleeding or clotting complications in patients treated with rivaroxaban remains challenging. In addition, there is limited data on how coagulation tests perform in patients trea...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of North Carolina, Chapel Hill
NCT06393868 · Venous Thromboembolism, Gastro Intestinal Bleeding, and more
NCT07275476 · Fibrin Blood Clot, Pregnancy, and more
NCT04166825 · Fibrin Blood Clot, Infertility, Female, and more
NCT06541756 · Meniscus Tear, Meniscus Lesion, and more
NCT05095844 · COVID-19, Vaccine Adverse Reaction, and more
Carolina Point II
Chapel Hill, North Carolina
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions